Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (411-420 of 467) with videos related to

Pageof 47
Sort By:
Neurosurgical Review|August 19, 2022
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) surveyMaximilian J Mair, Philipp Lohmann, Norbert Galldiks, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Neuro-Oncology Practice|May 14, 2026
European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research projectEvangelia Razis, Thierry Gorlia, Matthias Preusser, et al.
Neuro-Oncology|August 26, 2025
Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET - a retrospective, bicentric cohort studyMaximilian J Mair, Jan-Michael Werner, Jonathan Weller, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2025
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterationsMarie Morfouace, Franck Bielle, Evangelia Razis, et al.
Journal of Neuropathology and Experimental Neurology|August 10, 2006
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe ConsortiumIrina Alafuzoff, Maria Pikkarainen, Safa Al-Sarraj, et al.
The Lancet. Oncology|May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomasMichael Weller, Martin van den Bent, Jörg C Tonn, et al.
Neuro-Oncology|July 4, 2024
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastasesRupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Pageof 47

Showing results (411-420 of 467) with videos related to

Sort By:
Pageof 47
Neurosurgical Review|August 19, 2022
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) surveyMaximilian J Mair, Philipp Lohmann, Norbert Galldiks, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Neuro-Oncology Practice|May 14, 2026
European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research projectEvangelia Razis, Thierry Gorlia, Matthias Preusser, et al.
Neuro-Oncology|August 26, 2025
Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET - a retrospective, bicentric cohort studyMaximilian J Mair, Jan-Michael Werner, Jonathan Weller, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2025
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterationsMarie Morfouace, Franck Bielle, Evangelia Razis, et al.
Journal of Neuropathology and Experimental Neurology|August 10, 2006
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe ConsortiumIrina Alafuzoff, Maria Pikkarainen, Safa Al-Sarraj, et al.
The Lancet. Oncology|May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomasMichael Weller, Martin van den Bent, Jörg C Tonn, et al.
Neuro-Oncology|July 4, 2024
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastasesRupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.
Pageof 47